Rentokil Initial plc (LON:RTO - Get Free Report)'s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 353.39 ($4.80) and traded as high as GBX 379.10 ($5.15). Rentokil Initial shares last traded at GBX 375.40 ($5.10), with a volume of 3,285,981 shares changing hands.
Wall Street Analysts Forecast Growth
A number of research analysts have recently weighed in on the stock. Royal Bank Of Canada restated an "outperform" rating and set a GBX 440 price target on shares of Rentokil Initial in a report on Friday, August 1st. JPMorgan Chase & Co. reiterated a "no recommendation" rating on shares of Rentokil Initial in a report on Monday, August 11th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of Rentokil Initial from GBX 425 to GBX 435 and gave the stock a "buy" rating in a report on Monday, July 21st. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of GBX 435.
Get Our Latest Report on RTO
Rentokil Initial Stock Performance
The firm's fifty day moving average price is GBX 361.52 and its 200-day moving average price is GBX 353.39. The company has a current ratio of 1.04, a quick ratio of 1.76 and a debt-to-equity ratio of 113.35. The company has a market cap of £9.42 billion, a P/E ratio of 2,919.01, a P/E/G ratio of 0.56 and a beta of 0.55.
About Rentokil Initial
(
Get Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.